{"database": "lobbying", "table": "lobbying_activities", "rows": [[1146643, "32208465-8c64-4443-8a60-8ee06580b950", "Q3", "NATIONAL VENTURE CAPITAL ASSOCIATION", 21687, "NATIONAL VENTURE CAPITAL ASSOCIATION", 2011, "third_quarter", "MED", "Personalized medicine: working with Congress to establish a regulatory approval and reimbursement path for advanced diagnostic products.  NVCA submitted comments to FDA and CMS on their FDA/CMA parallel review draft proposal", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office", null, 506930, 0, 0, "2011-10-11T15:36:10.037000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1146643"], "units": {}, "query_ms": 2.4735560873523355, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}